Richard C. Kurten

High Impact

Researcher

UAMS

Last publication 2024 Last refreshed 2026-05-16

faculty

31 h-index 123 pubs 3,616 cited

Research Areas

Links

ORCID Lab Website

OverviewAI-generated summary

Richard C. Kurten's research focuses on understanding the molecular and cellular mechanisms underlying various human and animal diseases, with a particular emphasis on respiratory and gastrointestinal conditions. His work investigates the roles of specific proteins, cytokines, and cellular processes in disease pathogenesis and potential therapeutic interventions.

Recent publications demonstrate his engagement with diverse research areas. These include studies on mucin packaging within secretory granules, the function of the cytokine LIGHT in esophageal fibroblasts related to eosinophilic esophagitis, and the impact of ORMDL3 expression on airway smooth muscle. Kurten has also explored the use of a human precision-cut lung slice platform for investigating SARS-CoV-2 pathogenesis and antiviral drug efficacy, as well as the effects of rhinovirus on human airways. Additionally, his research has touched upon the targeting of neurotransmitter systems to inhibit the growth of *Coxiella burnetii*.

Kurten maintains an active research laboratory and collaborates with colleagues at the University of Arkansas for Medical Sciences, including Joshua L. Kennedy, Priyangi A. Malaviarachchi, Duah Alkam, and Srijon K. Banerjee. His scholarly output is reflected in a h-index of 31, with over 123 publications and more than 3,500 citations, designating him as a highly cited researcher.

Metrics

h-index: 31
Publications: 123
Citations: 3,616

Selected Publications

An <i>ex vivo</i> human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy (2024)

8 citations DOI OpenAlex
Mechanotransduction-induced interplay between phospholamban and yes-activated protein induces smooth muscle cell hypertrophy (2024)

4 citations DOI OpenAlex
Rhinovirus C15 Attenuates Relaxation and cAMP Production in Human Airways and Smooth Muscle (2023)

8 citations DOI OpenAlex
An <i>ex vivo</i> human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy (2023)

3 citations DOI OpenAlex
A Deficiency in the Cytokine TNFSF14/LIGHT Limits Inflammation and Remodeling in Murine Eosinophilic Esophagitis (2022)

21 citations DOI OpenAlex
Mucin Expression in Human Precision-Cut Lung Slices (2022)

DOI OpenAlex
Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules (2022)

26 citations DOI OpenAlex
Reduced AIBP expression in bronchial epithelial cells of asthmatic patients: Potential therapeutic target (2022)

4 citations DOI OpenAlex
Esophageal Fibroblasts are the Players in the Interferon Response in Eosinophilic Esophagitis (2022)

3 citations DOI OpenAlex
LIGHT controls distinct homeostatic and inflammatory gene expression profiles in esophageal fibroblasts via differential HVEM and LTβR-mediated mechanisms (2021)

25 citations DOI OpenAlex
Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells (2021)

5 citations DOI OpenAlex
ORMDL3 expression in ASM regulates hypertrophy, hyperplasia via TPM1 and TPM4, and contractility (2021)

14 citations DOI OpenAlex
Integrative Proteomics and Phosphoproteomics of Asthmatic Airways following RV Infection (2021)

DOI OpenAlex
A unique esophageal extracellular matrix proteome alters normal fibroblast function in severe eosinophilic esophagitis (2021)

25 citations DOI OpenAlex